Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 474903생성일: 2026년 10월 25일
8-Hydroxyquinoline → tert-Butyl 10-methyl-8-(2-oxo-4-(5-(trifluoromethyl)pyridin-2-yl)pyridin-1(2H)-yl)-3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxylate
https://huagongshe.com/reaction/474903
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 8-Hydroxyquinoline | HCID 1923 | — |
| 반응물 | Cesium carbonate | HCID 10796 | — |
| 반응물 | 4-(5-(Trifluoromethyl)pyridin-2-yl)pyridin-2(1H)-one | HCID 57625523 | — |
| 반응물 | tert-Butyl 8-bromo-10-methyl-3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxylate | HCID 58093410 | — |
| 촉매 | Copper iodide | HCID 83717 | — |
| 용매 | Dimethyl Sulfoxide | HCID 679 | — |
| 생성물 | tert-Butyl 10-methyl-8-(2-oxo-4-(5-(trifluoromethyl)pyridin-2-yl)pyridin-1(2H)-yl)-3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxylate | HCID 66873731 | 29.5% |
반응 단계
tert-Butyl 8-bromo-10-methyl-3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxylate (0.15 g, 0.39 mmol), 4-(5-(trifluoromethyl)pyridin-2-yl)pyridin-2(1H)-one (0.13 g, 0.54 mmol), and Cs2CO3 (0.19 g, 0.60 mmol) were suspended in DMSO (3.3 mL), and the air was removed under vacuum for 15 min. The system was flushed with Ar, and 8-hydroxyquinoline (23 mg, 0.16 mmol) and copper iodide (0.13 g, 0.59 mmol) were added to the suspension. The evacuation/Ar flushing process was repeated twice more, and the reaction mixture was heated at 130° C. for 18 h under N2. The mixture was cooled, diluted with 5:1 MeOH/NH4OH (15 mL), and the resulting solution was stirred at ambient temperature for 30 min. The reaction was further diluted with CH2Cl2 (75 mL). The resulting solution was filtered through silica gel, and the filtrate was concentrated under reduced pressure. The residue was diluted with CH2Cl2 and washed with brine (3×25 mL). The organic solution was dried over Na2SO4, filtered and concentrated to dryness. Flash chromatography (12 g ISCO column, (1:1 hexanes/EtOAc)/(80:18:2 CH2Cl2/MeOH/NH4OH), 100:0 for 5 column volumes, increased to 50:50 over 20 column volumes and held for 5 column volumes; increased to 0:100 over 20 column volumes and held for 5 column volumes) followed by preparative HPLC (Phenomenex Luna C18 (2), 250.0×50.0 mm, 10 micron, H2O with 0.05% TFA and CH3CN with 0.05% TFA) gave the title compound (62 mg, 20%) as a yellow solid: 1H NMR (500 MHz, CDCl3) δ 9.00 (s, 1H), 8.06 (d, J=8.5 Hz, 1H), 7.91 (d, J=7.5 Hz, 1H), 7.60-7.57 (m, 2H), 7.35-7.32 (m, 1H), 7.28-7.26 (s, 1H), 7.08-7.02 (m, 2H), 4.68-4.64 (m, 2H), 3.78-3.74 (m, 4H), 3.71-3.69 (m, 1H), 2.95-2.94 (m, 2H), 1.96-1.91 (m, 2H), 1.43 (s, 9H); ESI MS m/z 539 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08637501B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_01 |
|---|
| ORD ID | ord-9b7bea22bdff44da8bfc4ea9030846f8 |
|---|
| 출처 메모 | uspto-grants-2014_01 |
|---|